informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
|2||Active, not recruiting||
PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
|3||Not yet recruiting||
A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
† Study has passed its completion date and status has not been verified in more than two years.